Huyghe M, Desterke C, Imeri J, Belliard N, Chaker D, Oudrirhi N
Front Immunol. 2024; 15:1463736.
PMID: 39445004
PMC: 11496199.
DOI: 10.3389/fimmu.2024.1463736.
Xu J, Gao H, Azhar M, Xu H, Chen S, Li M
Front Immunol. 2024; 15:1449441.
PMID: 39380989
PMC: 11459090.
DOI: 10.3389/fimmu.2024.1449441.
Lan W, Li J, Ye Z, Liu Y, Luo S, Lu X
EMBO J. 2024; 43(9):1722-1739.
PMID: 38580775
PMC: 11065989.
DOI: 10.1038/s44318-024-00079-4.
Hazrati A, Malekpour K, Khorramdelazad H, Rajaei S, Hashemi S
Biomark Res. 2024; 12(1):35.
PMID: 38515166
PMC: 10958918.
DOI: 10.1186/s40364-024-00580-2.
Zhao X, Lin M, Huang X
Med Rev (2021). 2024; 3(4):305-320.
PMID: 38235405
PMC: 10790210.
DOI: 10.1515/mr-2023-0031.
Dysregulation of DNAM-1-Mediated NK Cell Anti-Cancer Responses in the Tumor Microenvironment.
Paolini R, Molfetta R
Cancers (Basel). 2023; 15(18).
PMID: 37760586
PMC: 10527063.
DOI: 10.3390/cancers15184616.
Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires.
Philippon C, Tao S, Clement D, Haroun-Izquierdo A, Kichula K, Netskar H
Blood Adv. 2023; 7(16):4492-4504.
PMID: 37327114
PMC: 10440473.
DOI: 10.1182/bloodadvances.2023009827.
NK cell education: Physiological and pathological influences.
Rascle P, Woolley G, Jost S, Manickam C, Reeves R
Front Immunol. 2023; 14:1087155.
PMID: 36742337
PMC: 9896005.
DOI: 10.3389/fimmu.2023.1087155.
Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
Rodriguez-Rodriguez N, Clark P, Gogoi M, Ferreira A, Kerscher B, Crisp A
Proc Natl Acad Sci U S A. 2022; 119(49):e2203454119.
PMID: 36442116
PMC: 7614094.
DOI: 10.1073/pnas.2203454119.
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints.
Franzese O, Graziani G
Cancers (Basel). 2022; 14(22).
PMID: 36428727
PMC: 9688455.
DOI: 10.3390/cancers14225633.
Dynamic of Circulating DNAM-1+ Monocytes and NK Cells in Patients with STEMI Following Primary Percutaneous Coronary Intervention.
Kumric M, Urlic H, Bilalic A, Rezic-Muzinic N, Mastelic A, Markotic A
J Cardiovasc Dev Dis. 2022; 9(11).
PMID: 36421930
PMC: 9693248.
DOI: 10.3390/jcdd9110395.
Bone marrow mesenchymal stem cells regulate the dysfunction of NK cells via the T cell immunoglobulin and ITIM domain in patients with myelodysplastic syndromes.
Liu Z, Guo Y, Huang L, Jia Y, Liu H, Peng F
Cell Commun Signal. 2022; 20(1):169.
PMID: 36303184
PMC: 9615182.
DOI: 10.1186/s12964-022-00985-2.
Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia.
Hussein B, Hallner A, Wennstrom L, Brune M, Martner A, Hellstrand K
Front Immunol. 2021; 12:796072.
PMID: 34956230
PMC: 8695486.
DOI: 10.3389/fimmu.2021.796072.
Dynamic variability in SHP-1 abundance determines natural killer cell responsiveness.
Wu Z, Park S, Lau C, Zhong Y, Sheppard S, Sun J
Sci Signal. 2021; 14(708):eabe5380.
PMID: 34752140
PMC: 8791782.
DOI: 10.1126/scisignal.abe5380.
CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients.
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez M, Martinez-Sanchez M, Lopez-Cubillana P, Fuster J
Oncoimmunology. 2021; 10(1):1986943.
PMID: 34676148
PMC: 8525952.
DOI: 10.1080/2162402X.2021.1986943.
LIR-1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody-dependent cellular cytotoxicity.
Leijonhufvud C, Reger R, Segerberg F, Theorell J, Schlums H, Bryceson Y
Clin Transl Immunology. 2021; 10(10):e1346.
PMID: 34631057
PMC: 8491220.
DOI: 10.1002/cti2.1346.
Licensing Natural Killers for Antiviral Immunity.
Cronk J, Fafoutis E, Brown M
Pathogens. 2021; 10(7).
PMID: 34358058
PMC: 8308748.
DOI: 10.3390/pathogens10070908.
Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56CD16NKp80 and Express KIR2DL2/DL3 and KIR3DL1.
Euchner J, Sprissler J, Cathomen T, Furst D, Schrezenmeier H, Debatin K
Front Immunol. 2021; 12:640672.
PMID: 34017328
PMC: 8129508.
DOI: 10.3389/fimmu.2021.640672.
The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice.
Shreeve N, Depierreux D, Hawkes D, Traherne J, Sovio U, Huhn O
Immunity. 2021; 54(6):1231-1244.e4.
PMID: 33887202
PMC: 8211638.
DOI: 10.1016/j.immuni.2021.03.021.
Analysis of the Characteristics of TIGIT-Expressing CD3CD56NK Cells in Controlling Different Stages of HIV-1 Infection.
Zhang X, Lu X, Cheung A, Zhang Q, Liu Z, Li Z
Front Immunol. 2021; 12:602492.
PMID: 33717085
PMC: 7953050.
DOI: 10.3389/fimmu.2021.602492.